Microtubule-stabilizing agents: New drug discovery and cancer therapy-Reference-Cited by-同舟云学术

Microtubule-stabilizing agents: New drug discovery and cancer therapy

Published:2016-06 Issue: Volume:162 Page:134-143
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Zhao Ying,Mu Xin,Du Guanhua

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference149 articles.

1. Epothilone B and its analogs—a new family of anticancer agents;Altmann;Mini Rev Med Chem,2003

2. Recent developments in the chemical biology of epothilones;Altmann;Curr Pharm Des,2005

3. 4. The natural products epothilones A and B as lead structures for anticancer drug discovery: chemistry, biology, and SAR studies;Altmann;Prog Med Chem,2004

4. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives;Altmann;Mol Divers,2011

5. Epothilones as lead structures for new anticancer drugs-pharmacology, fermentation, and structure–activity-relationships;Altmann;Prog Drug Res,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD133+/ABCC5+ cervical cancer cells exhibit cancer stem cell properties;Heliyon;2024-09

2. Approaches for the discovery of cinnamic acid derivatives with anticancer potential;Expert Opinion on Drug Discovery;2024-08-06

3. Cancer nuclear envelope rupture and repair in taxane resistance;Medical Review;2024-06-05

4. TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis;Frontiers in Molecular Biosciences;2024-05-02

5. First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway;Acta Pharmaceutica Sinica B;2024-05